[PDF][PDF] Efficacy and safety of combination therapy with vildagliptin and metformin vs. metformin monotherapy for Type 2 Diabetes Mellitus therapy: a meta-analysis.
Y Ding, Y Liu, Y Qu, M Lin, F Dong, Y Li… - European Review for …, 2022 - europeanreview.org
OBJECTIVE: The aim is to assess the comparative efficacy and safety of combination
therapy with vildagliptin and metformin vs. metformin monotherapy in the treatment of type 2 …
therapy with vildagliptin and metformin vs. metformin monotherapy in the treatment of type 2 …
Dorzagliatin for Type 2 Diabetes Mellitus: A Systematic Review and Meta-analysis of Randomized Phase II/III Trials
F Lin, R He, B Ling, L Wang, T Jiang, B Yu - Clinical Therapeutics, 2023 - Elsevier
Purpose Dorzagliatin is a glucokinase agonist with effects on type 2 diabetes mellitus
(T2DM). This study included a meta-analysis on the efficacy and safety of dorzagliatin in the …
(T2DM). This study included a meta-analysis on the efficacy and safety of dorzagliatin in the …